The first-ever worldwide patient treatment with Elekta EVO at DTZ Berlin marks a groundbreaking moment in the evolution of adaptive radiotherapy and cancer care. This achievement sets a new benchmark for precision and patient safety in clinical practice, showcasing the power of innovation and collaboration.
Elekta EVO introduces a next-generation LINAC that seamlessly combines high-precision radiotherapy techniques with the latest advancements in AI-enhanced imaging.
The result? Unprecedented accuracy, reduced side effects, and improved quality of life for patients.
Online adaptive workflows, like those delivered with Elekta EVO, require real-time verification to ensure treatments are adapted and executed flawlessly.
IQM meets this demand with an innovative approach to quality assurance, replacing pre-treatment QA with comprehensive real-time verification during every fraction, ensuring unmatched accuracy and efficiency.
Here’s how IQM drives precision and confidence in adaptive radiotherapy:
- Real-time verification with IQM ensures every step of the adaptive treatment is delivered exactly as prescribed, minimizing the risk of missing the tumor or affecting healthy tissue.
- Unrivalled accuracy and unprecedented error detection – IQM uniquely verifies every individual beam segment and analyses errors in real-time, identifying and mitigating potential deviations during the adaptive treatment delivery process.
- Immediate feedback for every modern treatment technique – IQM enhances the precision, safety, and effectiveness of complex treatment techniques in online adaptive radiotherapy.
Celebrating Innovation and Collaboration
This milestone demonstrates the seamless integration of Elekta EVO and IQM, ensuring that adaptive radiotherapy is delivered with unmatched accuracy and confidence. The partnership between DTZ Berlin, Elekta, and iRT Systems is a testament to how cutting-edge technology and clinical expertise can come together to transform patient care.